Energy Production and Metabolism — MCQs

Energy Production and Metabolism Indian Medical PG Practice Questions and MCQs

Question 51: Carbon monoxide (CO) acts by inhibiting which component of the respiratory chain?

A. Cytochrome B
B. Cytochrome C oxidase (Correct Answer)
C. NADH CoQ reductase
D. Oxidative phosphorylation

Explanation: **Explanation:** The respiratory chain (Electron Transport Chain) consists of five complexes. **Carbon Monoxide (CO)** acts as a potent inhibitor of **Complex IV**, also known as **Cytochrome C oxidase**. It binds to the reduced form of iron ($Fe^{2+}$) in Cytochrome $a_3$, preventing the final transfer of electrons to oxygen. This halts the entire chain, leading to a cessation of ATP production and cellular hypoxia. **Analysis of Options:** * **Cytochrome C oxidase (Correct):** CO, along with Cyanide ($CN^-$), Hydrogen Sulfide ($H_2S$), and Azides, specifically targets this complex, blocking the reduction of $O_2$ to $H_2O$. * **Cytochrome B (Incorrect):** This is a component of Complex III. Inhibitors of Complex III include **Antimycin A** and British Anti-Lewisite (BAL). * **NADH CoQ reductase (Incorrect):** This refers to Complex I. Common inhibitors include **Rotenone**, Amobarbital (Amytal), and Piericidin A. * **Oxidative phosphorylation (Incorrect):** This is a broad term for the entire process. While CO inhibits the process, the specific target is a component of the chain. A specific inhibitor of the phosphorylation step (Complex V/ATP Synthase) is **Oligomycin**. **Clinical Pearls for NEET-PG:** 1. **Cyanide vs. CO:** Both inhibit Complex IV. However, CO also binds to hemoglobin (forming Carboxyhemoglobin), shifting the oxygen-dissociation curve to the **left**, further impairing oxygen delivery. 2. **Uncouplers:** Unlike inhibitors, uncouplers (e.g., 2,4-DNP, Thermogenin) increase oxygen consumption but **decrease** ATP synthesis by dissipating the proton gradient. 3. **Complex II Inhibitor:** Carboxin and Malonate (competitive inhibitor of Succinate Dehydrogenase).

Question 52: What is the P:O ratio for FAD?

A. 3
B. 2.5
C. 1.5 (Correct Answer)
D. 4

Explanation: **Explanation:** The **P:O ratio** (Phosphate-to-Oxygen ratio) refers to the number of ATP molecules synthesized per pair of electrons transferred through the Electron Transport Chain (ETC) to reduce one atom of oxygen. **Why 1.5 is the correct answer:** Electrons from **FADH₂** enter the ETC at **Complex II** (Succinate Dehydrogenase). Because they bypass Complex I, they miss the first proton-pumping site. Consequently, FADH₂ only triggers the pumping of **6 protons** (4 at Complex III and 2 at Complex IV). According to current bioenergetic models, it takes approximately 4 protons to synthesize and export 1 ATP (3 for the ATP synthase rotor and 1 for phosphate transport). Therefore, 6 protons ÷ 4 protons/ATP = **1.5 ATP**. **Analysis of Incorrect Options:** * **Option A (3) & Option B (2.5):** These values represent the P:O ratio for **NADH**. NADH enters at Complex I, pumping a total of 10 protons. 2.5 is the modern (experimentally verified) value, while 3 is the older "classical" value. * **Option D (4):** This value does not correspond to a standard P:O ratio for any common respiratory substrate in human metabolism. **NEET-PG High-Yield Pearls:** * **Modern vs. Classical:** Always prioritize modern values (**NADH = 2.5, FADH₂ = 1.5**) unless the question specifically asks for "classical" values (3 and 2, respectively). * **Complexes:** Remember that Complex II is the only complex that **does not pump protons** across the inner mitochondrial membrane. * **Total ATP Yield:** Using modern P:O ratios, the complete oxidation of one glucose molecule yields **30 or 32 ATP** (depending on the shuttle used), rather than the older estimate of 36 or 38.

Question 53: Cytochrome oxidase contains which of the following elements?

A. Ca++
B. Cu (Correct Answer)
C. Mn
D. Zn

Explanation: **Explanation:** **Cytochrome oxidase (Complex IV)** is the terminal enzyme of the mitochondrial electron transport chain (ETC). Its primary function is to transfer electrons from reduced cytochrome c to molecular oxygen, reducing it to water. **Why Copper (Cu) is correct:** Cytochrome oxidase is a large transmembrane protein complex that contains **two heme groups** (a and a3) and **two copper centers** (CuA and CuB). * **CuA center:** Receives electrons from cytochrome c. * **CuB center:** Linked to heme a3, it forms the site where molecular oxygen ($O_2$) binds and is reduced. The presence of copper is essential for the redox activity of the enzyme; hence, copper deficiency can impair mitochondrial respiration. **Why other options are incorrect:** * **A. Calcium (Ca++):** While calcium is a vital secondary messenger and cofactor for enzymes like α-ketoglutarate dehydrogenase, it does not play a direct role in the electron transfer process of Complex IV. * **C. Manganese (Mn):** Mn is a cofactor for **Superoxide Dismutase (Mn-SOD)** found in mitochondria and Pyruvate Carboxylase, but not for cytochrome oxidase. * **D. Zinc (Zn):** Zinc is a structural component of many enzymes (e.g., Carbonic Anhydrase, Alcohol Dehydrogenase) and "zinc finger" proteins, but it is not a redox-active metal in the ETC. **High-Yield Clinical Pearls for NEET-PG:** 1. **Inhibitors:** Cytochrome oxidase (Complex IV) is inhibited by **Cyanide, Carbon Monoxide (CO), Hydrogen Sulfide ($H_2S$), and Azide**. These bind to the iron/copper centers, halting ATP production. 2. **Menkes Disease:** A defect in copper absorption leads to decreased activity of copper-dependent enzymes, including cytochrome oxidase, causing neurological symptoms and "kinky" hair. 3. **Iron & Copper:** Remember that Complex IV requires **both** Iron (in heme) and Copper to function.

Question 54: Amobarbital inhibits which complex in the electron transport chain?

A. Complex I (Correct Answer)
B. Complex II
C. Complex III
D. Complex IV

Explanation: **Explanation:** The Electron Transport Chain (ETC) is the final stage of aerobic respiration, where electrons are transferred through a series of protein complexes to generate a proton gradient for ATP synthesis. **Correct Answer: A. Complex I (NADH: Coenzyme Q Oxidoreductase)** Amobarbital (a barbiturate) acts as a potent inhibitor of Complex I. It binds to the complex and prevents the transfer of electrons from NADH to Coenzyme Q (Ubiquinone). This halts the proton pumping at this stage, significantly reducing the proton motive force and subsequent ATP production. **Incorrect Options:** * **Complex II (Succinate Dehydrogenase):** Inhibited by **Malonate** (competitive inhibitor) and **Carboxin**. Complex II is unique as it does not pump protons and is also part of the TCA cycle. * **Complex III (Cytochrome bc1 complex):** Inhibited by **Antimycin A** and **British Anti-Lewisite (BAL)**. These block electron transfer from Cytochrome b to Cytochrome c1. * **Complex IV (Cytochrome c Oxidase):** Inhibited by **Cyanide (CN⁻)**, **Carbon Monoxide (CO)**, **Azide (N₃⁻)**, and **Hydrogen Sulfide (H₂S)**. These bind to the iron (heme) or copper centers, preventing the final reduction of Oxygen to Water. **High-Yield Clinical Pearls for NEET-PG:** * **Complex I Inhibitors Mnemonic:** "The **P**i**R**A**T**e" – **P**iericidin A, **R**otenone, **A**mobarbital (Amytal), and **T**halicarpine. * **MPTP**, a contaminant in illicit drugs, is converted to MPP+, which inhibits Complex I and causes permanent Parkinsonian symptoms. * **Uncouplers** (e.g., 2,4-DNP, Thermogenin) differ from inhibitors; they dissipate the proton gradient without blocking the electron flow, leading to heat production instead of ATP synthesis.

Question 55: Mitochondria is involved in all of the following processes, except:

A. ATP production
B. Apoptosis
C. Tricarboxylic acid cycle
D. Fatty acid biosynthesis (Correct Answer)

Explanation: **Explanation:** The correct answer is **D. Fatty acid biosynthesis**. This is because fatty acid synthesis (De novo lipogenesis) occurs primarily in the **cytosol**, not the mitochondria. The process requires NADPH and Acetyl-CoA; while Acetyl-CoA is produced in the mitochondria, it must be transported to the cytosol via the "Citrate Shuttle" to participate in synthesis. **Why the other options are incorrect:** * **A. ATP production:** Mitochondria are the "powerhouse of the cell." The Electron Transport Chain (ETC) and Oxidative Phosphorylation occur on the inner mitochondrial membrane to generate the bulk of cellular ATP. * **B. Apoptosis:** Mitochondria play a central role in the intrinsic pathway of apoptosis. The release of **Cytochrome c** from the mitochondrial intermembrane space into the cytosol activates caspases, leading to programmed cell death. * **C. Tricarboxylic acid (TCA) cycle:** All enzymes of the Kreb’s cycle (except succinate dehydrogenase, which is on the inner membrane) are located in the **mitochondrial matrix**. **High-Yield NEET-PG Pearls:** * **Metabolic "Double Agents":** Processes occurring in **both** mitochondria and cytosol include **H**eme synthesis, **U**rea cycle, and **G**luconeogenesis (Mnemonic: **HUG**). * **Fatty Acid Oxidation (Beta-oxidation):** Unlike biosynthesis, the breakdown of fatty acids occurs inside the **mitochondria**. * **Mitochondrial DNA:** It is circular, double-stranded, and inherited exclusively from the **mother**. * **Marker Enzyme:** **Succinate dehydrogenase** is the marker enzyme for the inner mitochondrial membrane.

Question 56: At which complex in the electron transport chain does FADH2 enter?

A. Complex I
B. Complex II (Correct Answer)
C. Complex III
D. Complex IV

Explanation: **Explanation:** The Electron Transport Chain (ETC) is the final stage of aerobic respiration, where electrons from reduced coenzymes are transferred through a series of complexes to generate a proton gradient. **Why Complex II is correct:** FADH₂ (reduced flavin adenine dinucleotide) enters the ETC specifically at **Complex II**, also known as **Succinate Dehydrogenase**. This complex is unique because it is the only enzyme that participates in both the Citric Acid (TCA) Cycle and the ETC. It oxidizes succinate to fumarate, transferring electrons to FAD to form FADH₂, which then immediately donates those electrons to Coenzyme Q (Ubiquinone). Unlike other complexes, Complex II does not pump protons across the inner mitochondrial membrane, which is why FADH₂ yields less ATP (approx. 1.5) compared to NADH (approx. 2.5). **Why other options are incorrect:** * **Complex I (NADH Dehydrogenase):** This is the entry point for **NADH**. It transfers electrons to Coenzyme Q and pumps four protons. FADH₂ cannot enter here because its redox potential is higher than that of Complex I. * **Complex III (Cytochrome bc₁ complex):** This complex receives electrons from Coenzyme Q (which collects them from both Complex I and II) and passes them to Cytochrome c. * **Complex IV (Cytochrome c Oxidase):** This is the terminal complex where electrons are transferred to oxygen to form water. **High-Yield Clinical Pearls for NEET-PG:** * **Inhibitors:** Complex II is specifically inhibited by **Malonate** (competitive inhibitor) and **Carboxin**. * **Location:** All ETC complexes are integral proteins of the **inner mitochondrial membrane**. * **Iron-Sulfur (Fe-S) Centers:** These are present in Complexes I, II, and III and are crucial for electron transfer. * **Succinate Dehydrogenase:** It is the only TCA cycle enzyme encoded by nuclear DNA rather than mitochondrial DNA.

Question 57: Which metabolic cycle produces the least amount of energy?

A. Glycolysis
B. Kreb's cycle
C. HMP shunt (Correct Answer)
D. Fatty acid oxidation

Explanation: **Explanation:** The primary objective of the **HMP Shunt (Hexose Monophosphate Pathway)**, also known as the Pentose Phosphate Pathway, is not energy production but rather **biosynthesis and antioxidant defense**. Unlike other metabolic pathways, the HMP shunt does not involve the direct production or consumption of ATP. Instead, it generates **NADPH** (used for reductive biosynthesis of fatty acids and steroids) and **Ribose-5-phosphate** (for nucleotide synthesis). Therefore, it produces the least amount of energy (zero ATP). **Analysis of Options:** * **Glycolysis (Option A):** Produces a net gain of **2 ATP** per glucose molecule under anaerobic conditions and significantly more (via NADH) under aerobic conditions. * **Kreb’s Cycle (Option B):** The "powerhouse" of the cell, producing **10 ATP** per turn (via 3 NADH, 1 FADH2, and 1 GTP) through the electron transport chain. * **Fatty Acid Oxidation (Option D):** Highly energy-dense; for example, the complete oxidation of one molecule of Palmitate yields a net **106 ATP**. **Clinical Pearls for NEET-PG:** * **Rate-limiting enzyme:** Glucose-6-Phosphate Dehydrogenase (G6PD). * **G6PD Deficiency:** Leads to hemolytic anemia because the shunt is the only source of NADPH in RBCs, which is essential for maintaining reduced glutathione to combat oxidative stress. * **Site:** Occurs entirely in the **cytosol**. * **Key Organs:** Highly active in the liver, lactating mammary glands, adrenal cortex, and RBCs.

Question 58: Which reaction in the citric acid cycle results in the synthesis of a high-energy phosphate compound at the substrate level?

A. Citrate to α-ketoglutarate
B. α-ketoglutarate to succinate (Correct Answer)
C. Succinate to fumarate
D. Fumarate to malate

Explanation: ### Explanation **Correct Answer: B. α-ketoglutarate to succinate** In the Citric Acid Cycle (TCA cycle), the conversion of **Succinyl-CoA to Succinate** is the only step that involves **Substrate-Level Phosphorylation (SLP)**. While the question lists "α-ketoglutarate to succinate," this encompasses the two-step sequence where α-ketoglutarate is first decarboxylated to Succinyl-CoA, which is then converted to Succinate. During the cleavage of the high-energy thioester bond of Succinyl-CoA by the enzyme **Succinate thiokinase (Succinyl-CoA synthetase)**, energy is released to form **GTP** (in mammals) or ATP from GDP/ADP. This is unique because the high-energy phosphate is generated directly from the substrate without the involvement of the electron transport chain or oxygen. **Analysis of Incorrect Options:** * **A. Citrate to α-ketoglutarate:** This involves isomerization (to Isocitrate) followed by oxidative decarboxylation. It generates NADH but no high-energy phosphate. * **C. Succinate to fumarate:** This reaction is catalyzed by **Succinate dehydrogenase** (Complex II). It generates **FADH₂**, not a phosphate compound. * **D. Fumarate to malate:** This is a simple hydration reaction catalyzed by Fumarase; no energy is captured in this step. **High-Yield NEET-PG Pearls:** * **Enzyme:** Succinate thiokinase is the only enzyme in the TCA cycle performing SLP. * **GTP vs. ATP:** In the liver and kidneys, GTP is primarily formed; in heart and skeletal muscle, ATP is formed. * **Arsenite Poisoning:** Inhibits α-ketoglutarate dehydrogenase, halting the cycle before this SLP step can occur. * **Total Yield:** One turn of the TCA cycle produces **10 ATP** equivalents (3 NADH = 7.5, 1 FADH₂ = 1.5, 1 GTP = 1).

Question 59: What is the major source of Acetyl CoA?

A. Triglycerides
B. Fatty acids
C. Pyruvate (Correct Answer)
D. Alanine

Explanation: **Explanation:** The conversion of **Pyruvate to Acetyl CoA** via the **Pyruvate Dehydrogenase (PDH) Complex** is the definitive "bridge reaction" connecting glycolysis to the TCA cycle. In a well-fed state, glucose is the primary fuel source for most tissues (especially the brain and RBCs). Through glycolysis, glucose produces pyruvate, which enters the mitochondria to be decarboxylated into Acetyl CoA. This pathway represents the most consistent and significant flux of carbon into the TCA cycle for energy production under normal physiological conditions. **Analysis of Options:** * **Triglycerides (A):** These are storage forms of lipids. They must first be hydrolyzed into glycerol and fatty acids before they can contribute to energy metabolism. * **Fatty Acids (B):** While Beta-oxidation of fatty acids is a major source of Acetyl CoA during fasting, starvation, or high-fat diets, it is secondary to the glucose-pyruvate pathway in a standard metabolic state. * **Alanine (D):** This is a glucogenic amino acid. While it can be converted to pyruvate via transamination (ALT), it serves as a substrate for gluconeogenesis rather than being a "major" direct source of Acetyl CoA for daily energy needs. **Clinical Pearls for NEET-PG:** 1. **PDH Complex:** Requires five cofactors: **T**hiamine (B1), **R**iboflavin (B2), **N**iacin (B3), **P**antothenic acid (B5), and **L**ipoic acid (**T**ender **R**oving **N**ext **P**art **L**ove). 2. **Irreversibility:** The conversion of Pyruvate to Acetyl CoA is **irreversible**; hence, Acetyl CoA cannot be converted back to glucose (Fatty acids are not glucogenic). 3. **Arsenic Poisoning:** Arsenite inhibits the PDH complex by binding to the -SH groups of Lipoic acid, leading to lactic acidosis and neurological symptoms.

Question 60: Which of the following is an inhibitor of NADH-COQ reductase in the electron transport chain?

A. Rotenone (Correct Answer)
B. Phenformin
C. Carbon monoxide
D. Malonate

Explanation: **Explanation:** The Electron Transport Chain (ETC) consists of five complexes located in the inner mitochondrial membrane. **NADH-CoQ Reductase (Complex I)** is the first enzyme in the chain, responsible for transferring electrons from NADH to Coenzyme Q (Ubiquinone). **Why Rotenone is correct:** **Rotenone** is a classic inhibitor of **Complex I**. It binds to the enzyme and prevents the transfer of electrons from the iron-sulfur centers to ubiquinone. This halts the proton gradient formation at the earliest stage, leading to a decrease in ATP synthesis. **Analysis of Incorrect Options:** * **Phenformin:** While it can inhibit Complex I (similar to Metformin), it is primarily known for its association with lactic acidosis and is not the "textbook" classic inhibitor used to define Complex I in biochemical studies. * **Carbon Monoxide (CO):** This is a potent inhibitor of **Complex IV (Cytochrome c oxidase)**. It competes with oxygen for the binding site on heme $a_3$, effectively stopping the final step of electron transfer to oxygen. * **Malonate:** This is a competitive inhibitor of **Complex II (Succinate Dehydrogenase)**. It mimics the structure of succinate, thereby blocking the conversion of succinate to fumarate in the TCA cycle and the ETC. **High-Yield Clinical Pearls for NEET-PG:** * **Complex I Inhibitors:** Rotenone, Amobarbital (Amytal), Piericidin A, and MPTP (associated with Parkinsonism). * **Complex III Inhibitor:** Antimycin A. * **Complex IV Inhibitors:** Cyanide, CO, Sodium Azide, and Hydrogen Sulfide ($H_2S$). * **Complex V (ATP Synthase) Inhibitor:** Oligomycin. * **Uncouplers:** 2,4-Dinitrophenol (DNP), Thermogenin (Brown fat), and high doses of Aspirin. These dissipate the proton gradient as heat.

Practice by Chapter

Bioenergetics and Thermodynamics

Practice Questions

ATP as Energy Currency

Practice Questions

Tricarboxylic Acid Cycle

Practice Questions

Electron Transport Chain

Practice Questions

Oxidative Phosphorylation

Practice Questions

Mitochondrial Diseases

Practice Questions

Uncouplers and Inhibitors of Oxidative Phosphorylation

Practice Questions

Shuttle Systems: Malate-Aspartate and Glycerol-Phosphate

Practice Questions

Energy Yield from Nutrients

Practice Questions

Metabolic Rate and Basal Metabolism

Practice Questions

Brown Adipose Tissue and Thermogenesis

Practice Questions

Oxygen Toxicity and Free Radicals

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free